Corcept Therapeutics Incorporated (CORT) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$33.1
Day's range
$34.11

Corcept Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 12.15 M $489.82 M   0.74% 11.70%
INGALLS & SNYDER LLC 05/13/2026 7.61 M $306.71 M   5.75% 7.33%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 5.68 M $229.07 M   -1.32% 5.47%
05/08/2026 4.82 M $194.32 M   100.00% 4.64%
05/15/2026 4.08 M $164.35 M   100.00% 3.93%
PARALLEL ADVISORS, LLC 06/03/2026 3.98 M $160.33 M   2.53% 3.83%
STATE STREET CORP 05/15/2026 3.20 M $129.03 M   7.20% 3.08%
FMR LLC 05/15/2026 3.19 M $128.60 M   32.12% 3.07%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 2.71 M $109.40 M   1.67% 2.61%
FIRST TRUST ADVISORS LP 05/13/2026 2.17 M $87.61 M   213.48% 2.09%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 1.55 M $62.60 M   -4.15% 1.50%
TANG CAPITAL MANAGEMENT LLC 05/15/2026 1.50 M $60.47 M   856.85% 1.44%
UBS GROUP AG 05/05/2026 1.36 M $54.97 M   228.71% 1.31%
D. E. SHAW & CO., INC. 05/15/2026 1.18 M $47.62 M   596.27% 1.14%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 1.12 M $45.15 M   5.45% 1.08%
MORGAN STANLEY 05/15/2026 1.02 M $41.07 M   -36.00% 0.98%
CAPTION MANAGEMENT, LLC 05/15/2026 993.10 K $40.03 M   -11.29% 0.96%
BIOIMPACT CAPITAL LLC 05/15/2026 985.70 K $39.73 M   100.00% 0.95%
TWO SIGMA INVESTMENTS, LP 05/15/2026 945.88 K $38.13 M   3,283.11% 0.91%
CERITY PARTNERS LLC 05/15/2026 731.69 K $29.49 M   -3.13% 0.70%
GOLDMAN SACHS GROUP INC 05/15/2026 725.82 K $29.26 M   68.41% 0.70%
JANE STREET GROUP, LLC 05/12/2026 695.30 K $28.03 M   155.34% 0.67%
SIO CAPITAL MANAGEMENT, LLC 05/14/2026 674.76 K $27.20 M   100.00% 0.65%
NORTHERN TRUST CORP 05/14/2026 643.16 K $25.93 M   2.24% 0.62%
INVESCO LTD. 05/12/2026 628.38 K $25.33 M   -23.09% 0.61%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 590.31 K $23.80 M   100.00% 0.57%
MILLENNIUM MANAGEMENT LLC 05/15/2026 558.75 K $22.52 M   531.80% 0.54%
BANK OF NEW YORK MELLON CORP 05/05/2026 543.76 K $21.92 M   -6.52% 0.52%
BOSTON TRUST WALDEN CORP 04/24/2026 462.61 K $18.65 M   -12.32% 0.45%
PRINCIPAL FINANCIAL GROUP INC 05/04/2026 455.25 K $18.35 M   2.51% 0.44%
JANE STREET GROUP, LLC 05/12/2026 427.65 K $17.24 M   104.55% 0.41%
CITIGROUP INC 05/11/2026 421.07 K $16.97 M   1,133.75% 0.41%
AQR CAPITAL MANAGEMENT LLC 05/15/2026 406.21 K $15.87 M   -54.25% 0.39%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 345.00 K $13.91 M   -44.75% 0.33%
PUBLIC SECTOR PENSION INVESTMENT BOARD 05/13/2026 334.88 K $13.50 M   3.35% 0.32%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 330.10 K $13.31 M   -4.57% 0.32%
CANADA PENSION PLAN INVESTMENT BOARD 05/15/2026 324.90 K $13.10 M   161.17% 0.31%
FAS WEALTH PARTNERS, INC. 06/10/2026 322.37 K $12.99 M   3.98% 0.31%
FRANKLIN RESOURCES INC 05/13/2026 305.21 K $12.30 M   -34.81% 0.29%
KENNEDY CAPITAL MANAGEMENT LLC 05/13/2026 304.62 K $12.28 M   45.24% 0.29%
SOLEUS CAPITAL MANAGEMENT, L.P. 05/14/2026 285.53 K $11.51 M   100.00% 0.27%
VOLEON CAPITAL MANAGEMENT LP 05/15/2026 262.22 K $10.57 M   100.00% 0.25%
CAPTION MANAGEMENT, LLC 05/15/2026 260.00 K $10.48 M   100.00% 0.25%
CITADEL ADVISORS LLC 05/15/2026 254.22 K $10.25 M   -70.54% 0.24%
BOXER CAPITAL MANAGEMENT, LLC 05/15/2026 250.00 K $10.08 M   100.00% 0.24%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 230.73 K $9.30 M   100.00% 0.22%
LEGAL & GENERAL GROUP PLC 05/08/2026 219.68 K $8.86 M   -10.34% 0.21%
UBS ASSET MANAGEMENT AMERICAS INC 05/13/2026 217.47 K $8.77 M   6.03% 0.21%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 05/05/2026 214.57 K $9.01 M   -57.76% 0.21%
AMERIPRISE FINANCIAL INC 05/15/2026 212.07 K $8.55 M   -48.42% 0.20%

Corcept Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 545 institutional investors and hedge funds held shares of Corcept Therapeutics Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 12.15 M

INGALLS & SNYDER LLC: 7.61 M

RENAISSANCE TECHNOLOGIES LLC: 5.68 M

Parallel Advisors, LLC: 3.98 M

STATE STREET CORP: 3.2 M

FMR LLC: 3.19 M

76.58% of Corcept Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 108.58 M shares in the last 24 months. This purchase volume represents approximately $3.69 B in transactions.